According to our (Global Info Research) latest study, the global Borosilicate Glass Tubular Vial market size was valued at US$ 5830 million in 2025 and is forecast to a readjusted size of US$ 8230 million by 2032 with a CAGR of 5.0% during review period.
Borosilicate glass tubular vial are pharmaceutical packaging containers made from borosilicate medicinal glass tubes as raw materials, through processes such as tube cutting, flame forming, bottle mouth processing, bottle bottom forming, annealing, online detection, cleaning, and clean packaging. They mainly include medium borosilicate glass control bottles and high borosilicate glass control bottles, commonly used for packaging water injections, freeze-dried powder injections, biologics, vaccines, antibody drugs, oncology drugs, diagnostic reagents, and high-end generic drugs. Its characteristics are good water resistance, strong chemical stability, low precipitation on the inner surface, good thermal shock resistance, high dimensional accuracy, and uniform wall thickness. In 2025, global Borosilicate Glass Tubular Vial production reached approximately 78,694 M Units, with an average global market price of around US$ 72 per k unit.The annual production capacity of borosilicate glass tubular vial is 110 billion units, with a gross profit margin of about 25%.
The upstream mainly includes medium borosilicate medicinal glass tubes, low borosilicate medicinal glass tubes, sodium calcium glass tubes, borax, boric acid, quartz sand, soda ash, alumina, clarifying agents, natural gas, electricity, bottle making machines, pipe cutting equipment, flame forming equipment, annealing furnaces, online visual inspection equipment, cleaning equipment, sterilization equipment, clean packaging materials, pallets, cardboard boxes, and drug packaging material testing services.
The downstream mainly includes injection pharmaceutical companies, biopharmaceutical companies, vaccine companies, freeze-dried powder injection companies, antibody drug companies, oncology drug companies, anesthetic drug companies, diagnostic reagent companies, contract development and production organizations, sterile filling companies, hospital drug supply chains, and pharmaceutical distribution companies.
In the cost structure, medicinal glass tubes account for about 45%, energy accounts for about 16%, labor and manufacturing costs account for about 14%, equipment depreciation and molds account for about 8%, quality inspection and clean packaging account for about 7%, and logistics and other expenses account for about 10%.
The borosilicate glass tubular vial market is currently in the stage of increasing penetration rate of high-end pharmaceutical packaging materials, with core opportunities coming from the improvement of drug safety standards, consistency evaluation of injections, increased volume of biologics and vaccines, and the increasing demand for low precipitation, low particle, and high compatibility packaging materials from pharmaceutical companies. International enterprises still have advantages in borosilicate glass tubes, surface treatment, pharmaceutical certification, and global supply chains, while Chinese enterprises rely on domestic substitution of borosilicate glass, capacity expansion, and local pharmaceutical customer resources to accelerate their entry into the mid to high end market. In the future, the focus of competition will be on glass stability, full inspection capability, clean packaging, pre sterilized ready to use supply, and long-term customer certification. Enterprises with stable raw material supply and quality control capabilities are more likely to obtain high value-added orders.
This report is a detailed and comprehensive analysis for global Borosilicate Glass Tubular Vial market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Borosilicate Glass Tubular Vial market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/K Unit), 2021-2032
Global Borosilicate Glass Tubular Vial market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/K Unit), 2021-2032
Global Borosilicate Glass Tubular Vial market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/K Unit), 2021-2032
Global Borosilicate Glass Tubular Vial market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/K Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Borosilicate Glass Tubular Vial
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Borosilicate Glass Tubular Vial market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include SGD, SCHOTT Pharma, Gerresheimer AG, DWK Life Sciences, Stevanato Group, Corning, Nipro Corporation, Daikyo Seiko, West Pharmaceutical, Radpharm Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Borosilicate Glass Tubular Vial market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Low Borosilicate
Medium Borosilicate
High Borosilicate
Market segment by Appearance
Transparent Glass
Brown Glass
Market segment by Capacity
Capacity≤30ml
Capacity 30-100ml
Capacity≥100ml
Market segment by Application
Injection
Biological Products
Vaccines
Other
Major players covered
SGD
SCHOTT Pharma
Gerresheimer AG
DWK Life Sciences
Stevanato Group
Corning
Nipro Corporation
Daikyo Seiko
West Pharmaceutical
Radpharm Scientific
Pacific Vial Manufacturing
Ningbo Zhengli Pharmaceutical Packaging
Linuo Pharmaceutical Packaging
Chongqing Zhengchuan Pharmaceutical Packaging
Shandong Pharmaceutical Glass
CANGZHOU FOUR STARS GLASS
Anhui Huaxin Pharmaceutical Glass Products
Jiyuan Zhengyu Industrial
Taian Youlyy Industrial
Nantong Xinde Medical Packing Material
Chengdu Jingu Medicinal Packing
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Borosilicate Glass Tubular Vial product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Borosilicate Glass Tubular Vial, with price, sales quantity, revenue, and global market share of Borosilicate Glass Tubular Vial from 2021 to 2026.
Chapter 3, the Borosilicate Glass Tubular Vial competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Borosilicate Glass Tubular Vial breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Borosilicate Glass Tubular Vial market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Borosilicate Glass Tubular Vial.
Chapter 14 and 15, to describe Borosilicate Glass Tubular Vial sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Borosilicate Glass Tubular Vial. Industry analysis & Market Report on Borosilicate Glass Tubular Vial is a syndicated market report, published as Global Borosilicate Glass Tubular Vial Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Borosilicate Glass Tubular Vial market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.